These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12060035)

  • 1. Barrett's esophagus: so what!
    van Blankenstein M
    Dis Esophagus; 2002; 15(1):1-4. PubMed ID: 12060035
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's esophagus and cancer risk: a more realistic estimate.
    Rajendra S; Sharma P
    Semin Thorac Cardiovasc Surg; 2011; 23(4):261-2. PubMed ID: 22443641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
    Hur C
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):307-9. PubMed ID: 17257904
    [No Abstract]   [Full Text] [Related]  

  • 4. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F; Harewood GC; Patchett SE
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of adenocarcinoma in Barrett's oesophagus: population based study.
    Murray L; Watson P; Johnston B; Sloan J; Mainie IM; Gavin A
    BMJ; 2003 Sep; 327(7414):534-5. PubMed ID: 12958113
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-grade dysplasia in Barrett's esophagus.
    Odze RD; Goldblum JR
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
    [No Abstract]   [Full Text] [Related]  

  • 7. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
    de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
    Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for Barrett's esophagus.
    Zakko L; Lutzke L; Wang KK
    Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
    Curvers WL; ten Kate FJ; Krishnadath KK; Visser M; Elzer B; Baak LC; Bohmer C; Mallant-Hent RC; van Oijen A; Naber AH; Scholten P; Busch OR; Blaauwgeers HG; Meijer GA; Bergman JJ
    Am J Gastroenterol; 2010 Jul; 105(7):1523-30. PubMed ID: 20461069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of dysplastic Barrett's esophagus: where do we go from here?
    Peters JH
    Ann Surg Oncol; 2002 Apr; 9(3):215-6. PubMed ID: 11923124
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic diagnosis of subsquamous invasion of adenocarcinoma in short-segment Barrett's esophagus.
    Takahashi A; Oyama T
    Dig Endosc; 2017 Apr; 29 Suppl 2():38-39. PubMed ID: 28425664
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term endoscopic surveillance of Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 2003 Sep; 98(9):1912-3. PubMed ID: 14499764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.